Effect of Fatty Acids on Memory Performance of Toddlers
Conditions
Brief summary
Fatty acids or omega-3s are important in the human diet for brain development. Of the three main omega-3s (alpha-linolenic acid: ALA, 18:3n-3; eicosapentaenoic acid: EPA; 20:5n-3; docosahexaenoic acid: DHA, 22:6n-3), DHA and EPA have been studied extensively and have been shown to be important in brain function. Conversely, little is known about the effects of ALA even though the body can make DHA and EPA from it. Because the rate at which ALA makes DHA and EPA is very slow, ALA is not considered an important source of DHA and EPA. However, in the human diet, ALA is more readily available, more easily consumed, and less expensive relative to animal sources of DHA and EPA. So, it is very important that the investigators explore the effects of supplementation with ALA. It is possible that the ALA to DHA and EPA conversion rate can be altered by methylation, an epigenetic form of gene expression and regulation. In the present study, the investigators will examine memory abilities and genetic baselines in 16-month-olds. The investigators will then supplement their food with ALA or control oil for 4 months. At 20 months, the investigators will collect outcome data on memory, fatty acid status, genetic variations, and methylation. The investigators hypothesize that the ALA supplementation will result in an increase in the rate of ALA to DHA and EPA conversion through methylation and genetic variations and subsequently, memory abilities will improve. The data from this study will be used to design a larger R01 grant.
Interventions
Families will be asked to mix the contents of one capsule (1200 mg flaxseed oil or 1288 mg corn oil) into a cup of participants' food, twice a day.
Sponsors
Study design
Eligibility
Inclusion criteria
* 16-month-old toddlers and their natural mothers * Born fullterm and healthy with no complications * English as first language
Exclusion criteria
* Any toddler with a documented neurological or blood disorder will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in declarative memory performance | Baseline, 120 days |
Secondary
| Measure | Time frame |
|---|---|
| Change in fatty acid levels in plasma | Baseline, 120 days |
| Stability of methylation of promoter region of FADS2 gene | Baseline, 120 days |
Countries
United States